393 related articles for article (PubMed ID: 16246481)
21. Management and clinical outcomes of endometrial hyperplasia during a 13-year period in Songklanagarind Hospital.
Sirimusika N; Peeyananjarassri K; Suphasynth Y; Wootipoom V; Kanjanapradit K; Geater A
J Med Assoc Thai; 2014 Mar; 97(3):260-6. PubMed ID: 25123004
[TBL] [Abstract][Full Text] [Related]
22. Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia.
Bilgin T; Ozuysal S; Ozan H; Atakan T
J Obstet Gynaecol Res; 2004 Jun; 30(3):205-9. PubMed ID: 15210044
[TBL] [Abstract][Full Text] [Related]
23. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
24. Operative treatment of endometrial hyperplasia in kidney graft recipients: report of seven cases.
Bobrowska K; Pietrzak B; Jabiry-Zieniewicz Z; Cyganek A; Kaminski P; Wielgos M; Durlik M
Transplant Proc; 2007 Nov; 39(9):2756-8. PubMed ID: 18021979
[TBL] [Abstract][Full Text] [Related]
25. Hysteroscopic surgery does not adversely affect the long-term prognosis of women with endometrial adenocarcinoma.
Vilos GA; Edris F; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(2):205-10. PubMed ID: 17368258
[TBL] [Abstract][Full Text] [Related]
26. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Corrado G; Baiocco E; Carosi M; Vizza E
Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
[TBL] [Abstract][Full Text] [Related]
27. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
28. Predicting endometrial cancer among older women who present with abnormal vaginal bleeding.
Feldman S; Cook EF; Harlow BL; Berkowitz RS
Gynecol Oncol; 1995 Mar; 56(3):376-81. PubMed ID: 7705671
[TBL] [Abstract][Full Text] [Related]
29. Histopathologic consistency between endometrial hyperplasia diagnosis from endometrial curettage and pathologic diagnoses from hysterectomy specimens.
Jesadapatrakul S; Tangjitgamol S; Manusirivitaya S
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S16-21. PubMed ID: 17722313
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
31. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
Lasmar RB; Barrozo PR; de Oliveira MA; Coutinho ES; Dias R
J Minim Invasive Gynecol; 2006; 13(5):409-12. PubMed ID: 16962523
[TBL] [Abstract][Full Text] [Related]
32. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
Haimovich S; Checa MA; Mancebo G; Fusté P; Carreras R
Menopause; 2008; 15(5):1002-4. PubMed ID: 18451744
[TBL] [Abstract][Full Text] [Related]
33. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
[TBL] [Abstract][Full Text] [Related]
34. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
[TBL] [Abstract][Full Text] [Related]
35. Endometrial brush biopsy. An accurate outpatient method of detecting endometrial malignancy.
Wu HH; Casto BD; Elsheikh TM
J Reprod Med; 2003 Jan; 48(1):41-5. PubMed ID: 12611094
[TBL] [Abstract][Full Text] [Related]
36. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
[TBL] [Abstract][Full Text] [Related]
37. Management of endometrial hyperplasia: a retrospective analysis.
Triwitayakorn A; Rojanasakul A
J Med Assoc Thai; 1999 Jan; 82(1):33-9. PubMed ID: 10087736
[TBL] [Abstract][Full Text] [Related]
38. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
39. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study.
Kipp BR; Medeiros F; Campion MB; Distad TJ; Peterson LM; Keeney GL; Halling KC; Clayton AC
Cancer; 2008 Aug; 114(4):228-35. PubMed ID: 18548528
[TBL] [Abstract][Full Text] [Related]
40. Uterine body cancer mass screening at Tokai University Hospital.
Nagase E; Yasuda M; Kajiwara H; Osamura RY; Yoshitake T; Hirasawa T; Muramatsu T; Miyamoto T; Murakami M; Makino T; Ogawa T
Tokai J Exp Clin Med; 2004 Jun; 29(2):43-8. PubMed ID: 15473339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]